Although targeted therapies and immunotherapy have improved survival outcomes in many patients with lung cancer, these therapies come at a cost, not only financially but also in terms of cumulative ...
As I open my laptop in anticipation of another Friday deadline, the date tells me it’s time again for VALENTINE’S DAY?—oh no—the hype, opportunity, anticipation, stress, and expectations. How can a ...